TriageIQ™ | Universal Chronic Screener. Start Here.

Chronic

Risk

Assessments

Screen. Test. Treat.

by Diabetes Testing Centers™

Exclusively for Medical Providers

Early detection Changes Everything

Chronic Risk Assessments detect complications before they become life-threatening:

Up to 50% for Alzheimer's, 40% for Amputations, and 30% for CHF/Strokes.

Find what others miss

Chronic Risk Assessments by Diabetes Testing Centers™ (DTC) was founded by former family practice owners shaped by firsthand experience with late detection and preventable complications in everyday care. That perspective was further informed by enterprise healthcare management leadership in diagnostics and diabetes, guiding DTC’s development of scalable, non-invasive, reimbursable point-of-care programs. Today, with a national network of more than 20,000 independent practices, DTC helps CMS-ready and Cash-ready providers identify patient risks within the same visit through rapid, objective Chronic Risk Assessments.

Most Chronic Disease Progress Silently Across Four Areas:

🧠 Neurological Risk. Silent nerve and brain changes — including cognitive decline, neuropathy, and fall risk — often appear years before symptoms. Early detection allows providers to intervene before irreversible damage occurs.
❤️ Cardiometabolic Risk. Hypertension, diabetes complications, and vascular disease frequently progress without warning. Early screening reduces the risk of heart attack, stroke, and serious complications.
🧩 Behavioral Risk. Depression, sleep disorders, and behavioral health conditions directly worsen chronic disease outcomes. Early identification enables timely support and coordinated care.
🦶 Pain & Function Risk. Chronic pain and functional decline are often missed at intake. Routine, standardized screening at every visit closes the gap—supporting ICD-10 coding, treatment planning, and medical necessity.

TriageIQ™ is a proprietary universal chronic screener that identifies early neurological, cardiometabolic, behavioral, and pain/function risk signals in 1–2 minutes while establishing medical necessity for further assessment.

Detecting these risks earlier helps protect patients before complications become life-altering. DTC delivers the clinical science behind Chronic Risk Assessments and Chronic Care Programs trusted by specialists nationwide. Clinics can onboard flexibly, integrate seamlessly into existing workflows, and begin generating recurring revenue in under 30 days.*

Diabetes Damages. We Find Where.

Pick A pathway

The Universal Chronic Screener

TriageIQ™ is a proprietary 1–2 minute clinical intake engine that systematically identifies early neurological, cardiometabolic, behavioral, and pain-related risk signals—creating a scalable population health layer for chronic disease detection. DTC programs are delivered as a licensed model for healthcare organizations, MSOs, and provider groups building chronic care networks.

In-Clinic Screening

Remote/At-Home Screening*

Expand Patient Services

Diabetes Testing Centers™ (DTC) licenses turnkey Chronic Care Programs® that enable medical providers to identify, document, and treat chronic disease risks within the same visit — using rapid, non-invasive, and reimbursable workflows.

Each program is designed as a complete clinical pathway, integrating:

Universal Chronic Screening and risk stratification (TriageIQ™)
Proprietary Objective diagnostic assessments
Structured, audit-ready documentation
Defined treatment and therapy pathways
Ongoing monitoring and follow-up protocols

This allows providers to move from reactive care to proactive intervention — without adding staff, disrupting workflow, or taking on operational complexity. Direction Before Diagnosis.

Behavioral Screen/Tests (Ages 12+)

Cognitive Assessments

Patient Counseling/Education

Early Detection Matters

Early Detection Gives Families More Time and Memories to Share.

Early Testing Matters

Diabetes Testing Centers™ (DTC) helps both new and established medical providers unlock the full clinical and financial potential of early detection screening for diabetes patients. We go beyond routine glucose checks by offering CMS billable assessments and point-of-care reimbursable diagnostics that are faster, more impactful, and fully reimbursable. DTC transforms routine exams—including Annual Wellness Visits—into advanced preventive care encounters by combining reimbursable diagnostics, state-of-the-art early-detection technology, and chronic-care pathways that ensure compliance and payment integrity.

Our exclusive 25 Chronic Care Programs are designed for primary care and multispecialty settings and chronic patients. Built on the same protocols and equipment trusted by national specialty centers, each compact program can operate in a single room and deliver CMS-ready and Cash-ready programs—many of which do not require new staff, new construction, or disruption to your workflow. DTC helps clinics make productive use of brief gaps in the schedule with fast, non-invasive, CMS-aligned assessments that support both patient care and reimbursement. TriageIQ™ runs at every adult visit — establishing medical necessity, directing the right assessments, and ensuring no at-risk patient leaves unidentified.

By partnering with DTC, providers can screen smarter, intervene earlier, and transform routine checkups into life-saving opportunities—while building sustainable new revenue streams that strengthen their practice long-term.

Billable Testing

Following National Guidelines

National guidelines recommend that primary care physicians, endocrinologists, podiatrists, and neuropathy specialists screen all diabetic patients for neuropathy at least once a year. Neuropathy is one of the earliest and most common complications of diabetes, and its detection has important clinical implications.

Small fiber neuropathy is often the first sign of metabolic dysfunction or poorly controlled diabetes, serving as an early warning that systemic complications may be developing.
Large fiber neuropathy, on the other hand, is closely tied to loss of protective sensation—leading to falls, infections, wounds, and ultimately amputations and inspected at every visit once identified.

When neuropathy is detected, it not only signals nerve damage but also indicates an elevated risk of other serious diabetes-related complications such as cardiovascular disease, renal decline, and vision loss, all of which share the same underlying metabolic origin. When you can Screen, Test and Treat in-house and remotely, you not only keep patients under your care, you break the chain reaction at its source. That’s what makes our 25 Chronic Care Programs more than just assessments, they are the bridge between routine care and long-term health.

Failure to adopt advanced diagnostics is no longer just a clinical gap—it’s a legal risk. Courts have already set precedent, including Washington v. Washington Hospital (1990), holding providers accountable when available tools to detect risk earlier are not used.

Test First. Refer if Needed.

Reimbursable diagnostics

Most diabetic and chronic patients don't always see the specialists who could detect early complications because referrals are delayed, so the urgency is slowed and the disease progresses silently. The difference isn’t necessarily the visit itself—it’s the results of the diagnostic tests that help determine the plan of care for the patients. Traditional screening tools in PCP clinics are often outdated, limited in what they detect and non-reimbursable (e.g. monofilaments). DTC brings modern, clinically validated, reimbursable diagnostics into a practice, enabling primary care and multispecialty clinics to identify risks earlier and keep care in-house—before referrals are needed. Better detection. Better outcomes. Better Revenue.

Our Chronic Care Programs give providers a simple yet powerful way to intervene at this gateway. Through CMS billable assessments, reimbursable diagnostics, and early detection screenings, we help close care gaps while building new revenue streams. Instead of relying on outdated tools (e.g., fishing string for foot exams), replace them with modern, non-invasive diagnostic devices that are reimbursable and fit directly into existing workflows. The visit stays the same—the tools simply get better, the data becomes clearer, and the clinic is reimbursed for the care it is already providing.

Nearly 80% of people with diabetes will develop one or more complications over time, while only a small minority remain unaffected. Most patients are silently progressing toward cardiovascular disease, kidney damage, retinopathy, and preventable amputations. By the time many of these are discovered, the damage is often advanced, requiring costly specialist care and creating long-term burdens for patients and payers alike. DTC enables teams to deliver compliant, non-invasive screenings in just a few minutes without disrupting their primary services.

Primary Care & Multispecialty

Pain & Neurology
Endocrinology & Metabolism

Why Offer In-House Specialty Testing

Most diabetic patients never see the specialists who could detect early complications—referrals are delayed, visits are missed, and disease progresses silently. Primary care and multispecialty clinics are best positioned to catch problems early with in-office testing. Diabetes Testing Centers™ (DTC) makes this easy by integrating into one exam room and providing up to 25 reimbursable assessments for neuropathy, vascular, cognitive, metabolic risks, and more. This turnkey model helps clinics improve outcomes, retain revenue, and deliver specialty-level care where patients already are.

Screen for Complications

getting started

Primary Care Providers (PCP) check patients blood glucose but why stop there? With in-clinic neuropathy, cognitive, or vascular testing, you can diagnose earlier, act sooner, and keep care under your roof instead of waiting on outside referrals. Our assessments are designed to be completed quickly and comfortably, helping practices improve care delivery without adding operational strain.

This means you’re not just monitoring—you’re diagnosing, acting sooner, and keeping patients under your care with clinically valuable results that directly improve outcomes.

Getting Started Is Simple:

1. Identify Your Top 3 Referrals

Think about the top three patient referrals your clinic makes, like labs, neurology, podiatry, endocrinology, cardiology, physical therapy, or others. This helps you determine which patients have unmet needs that your clinic may fulfill.

2. Pick One: Assessment or Therapy

Review our Chronic Care Programs® and pick one that aligns with the referrals you make. For example, if you refer patients to neurology, choose our neuropathy testing program. If you refer to cardiology, consider our cardiovascular risk evaluation, etc.

3. Schedule a Meeting Below to Get Started

Select a program with a zero-down option to begin testing these patients immediately in your clinic, without any upfront investment and get a financial pro forma from us based on your location and payor reimbursements. This allows you to start providing and billing for these services, regularly in 30 days or less.

Early Detection Anywhere

Schedule Below to Learn More

"Book a 15‑minute walkthrough” to see how easily DTC programs integrate into your existing workflows.

Test Before You Refer

Page updated

Report abuse